TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence

被引:30
|
作者
Cassar, Lucy [1 ]
Nicholls, Craig [1 ]
Pinto, Alex R. [1 ]
Chen, Ruping [2 ]
Wang, Lihui [2 ]
Li, He [1 ]
Liu, Jun-Ping [1 ,2 ]
机构
[1] Monash Univ, Cent Eastern Clin Sch, Dept Immunol, Mol Signaling Lab, Prahran, Vic 3181, Australia
[2] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou 311121, Zhejiang, Peoples R China
基金
中国国家自然科学基金; 英国医学研究理事会;
关键词
BMPRII; TGFbeta; hTERT; telomerase; telomeres; senescence; breast cancer cells; BONE MORPHOGENETIC PROTEIN-7; TERT PROMOTER MUTATIONS; GROWTH-FACTOR-BETA; IN-VIVO; C-MYC; HTERT GENE; MESENCHYMAL TRANSITION; TUMOR-GROWTH; MOUSE CELLS; TRANSCRIPTION;
D O I
10.1007/s13238-016-0322-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Human telomerase reverse transcriptase (hTERT) plays a central role in telomere lengthening for continuous cell proliferation, but it remains unclear how extracellular cues regulate telomerase lengthening of telomeres. Here we report that the cytokine bone morphogenetic protein-7 (BMP7) induces the hTERT gene repression in a BMPRII receptor- and Smad3-dependent manner in human breast cancer cells. Chonic exposure of human breast cancer cells to BMP7 results in short telomeres, cell senescence and apoptosis. Mutation of the BMPRII receptor, but not TGFbRII, ACTRIIA or ACTRIIB receptor, inhibits BMP7-induced repression of the hTERT gene promoter activity, leading to increased telomerase activity, lengthened telomeres and continued cell proliferation. Expression of hTERT prevents BMP7-induced breast cancer cell senescence and apoptosis. Thus, our data suggest that BMP7 induces breast cancer cell aging by a mechanism involving BMPRII receptor- and Smad3-mediated repression of the hTERT gene.
引用
收藏
页码:39 / 54
页数:16
相关论文
共 50 条
  • [21] Tetracycline regulatable transgenic mouse model for TGF-beta signalling: Inhibition of TGF-beta pathway in hematopoietic cells by dominant negative TGF-beta receptor II.
    Mikkola, H
    Valdimarsdottir, G
    Andersson, E
    Larsson, J
    Jacobsen, SE
    ten Dijke, P
    Karlsson, S
    BLOOD, 1999, 94 (10) : 686A - 686A
  • [22] INACTIVATION OF THE RETINOBLASTOMA GENE DOES NOT LEAD TO LOSS OF TGF-BETA RECEPTORS OR RESPONSE TO TGF-BETA IN BREAST-CANCER CELL-LINES
    ONG, G
    SIKORA, K
    GULLICK, WJ
    ONCOGENE, 1991, 6 (05) : 761 - 763
  • [23] Glucose-induced expression of TGF-beta and TGF-beta receptor in VSMC is mediated by protein kinase C alpha.
    Lindschau, C
    Quass, P
    Drab, M
    Luft, FC
    Haller, H
    HYPERTENSION, 1997, 30 (03) : P151 - P151
  • [24] Activation of TGF-beta signalling in breast cancer metastatic cells
    S Giampieri
    E Sahai
    Breast Cancer Research, 10
  • [25] Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3 (Retraction of vol 23, pg 1880, 2009)
    Cassar, Lucy
    Nicholls, Craig
    Pinto, Alex R.
    Li, He
    Liu, Jun-Ping
    FASEB JOURNAL, 2009, 23 (08): : 2790 - 2790
  • [26] Activation of TGF-beta signalling in breast cancer metastatic cells
    Giampieri, S.
    Sahai, E.
    BREAST CANCER RESEARCH, 2008, 10 : S3 - S4
  • [27] TGF-beta in the Bone Microenvironment: Role in Breast Cancer Metastases
    Buijs, Jeroen T.
    Stayrook, Keith R.
    Guise, Theresa A.
    CANCER MICROENVIRONMENT, 2011, 4 (03) : 261 - 281
  • [28] The role of the type III TGF-beta receptor in prostate cancer
    Turley, Ryan S.
    Finger, Elizabeth C.
    Fields, Timothy A.
    Blobe, Gerard C.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 94 - 94
  • [29] Functional role of TGF-beta receptor type-2 in breast cancer progression and survival
    Srivastava, Meera
    Bera, Alakesh
    Pollard, Harvey B.
    Hu, Hai
    Shriver, Craig D.
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Inhibition of tankyrase 1 in human gastric cancer cells enhances telomere shortening by telomerase inhibitors
    Zhang, Hao
    Yang, Meng-Hua
    Zhao, Jing-Jing
    Chen, Ling
    Yu, Song-Tao
    Tang, Xu-Dong
    Fang, Dian-Chun
    Yang, Shi-Ming
    ONCOLOGY REPORTS, 2010, 24 (04) : 1059 - 1065